secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2022-12-22T23:59:59+00:00
Accession:  0001493152-22-036302
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics issues $3.3M 8% convertible debenture and warrant to Alpha Capital
--------------------------------------------------------------------------------

- Issued $3.3M principal debenture for $3M purchase price; 8% interest starts Dec 2023, payable quarterly.
- Conversion price $1.32/share; warrant for 2.5M shares at exercise price $1.65, exercisable from June 2023 to June 2028.
- Proceeds to advance QN-302 IND candidate toward clinical trials and for working capital.
- Monthly redemption of $110k+ interest begins June 2023, with optional redemption at 105% of principal.
- Debenture and warrant unregistered, issued under Section 4(a)(2) exemption; registration rights agreement filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315222036302/0001493152-22-036302-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315222036302/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-036302

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer